Optiscan Imaging Limited (AU:OIL) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Optiscan Imaging Limited has entered a collaborative research agreement with the University of Minnesota’s College of Veterinary Medicine to enhance its imaging system for use in the veterinary market, initially focusing on cancer research in companion animals. This partnership aims to demonstrate Optiscan’s technology as a transformative diagnostic tool in veterinary care, targeting a rapidly growing market valued at $11.92 billion in 2022. By integrating real-time imaging solutions, Optiscan seeks to revolutionize veterinary diagnostics and treatments, promising improved health outcomes for animals.
For further insights into AU:OIL stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Too Late to Jump In,’ Says Ladenburg About SoundHound AI Stock
- ‘Hold Your Horses,’ Says Jefferies About Apple Stock
- All Eyes on Nvidia Stock Ahead of Earnings; Here’s What Oppenheimer Expects
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
